Transplant Genomics is at the forefront of personalized medicine for organ transplant recipients. Our innovative genomic testing solutions provide critical insights into transplant health, enabling physicians to make more informed decisions about immunosuppression management. By leveraging cutting-edge technology and advanced analytics, we're revolutionizing post-transplant care, improving long-term outcomes, and enhancing the quality of life for transplant patients. Our flagship product, TruGraf, is a non-invasive blood test that helps clinicians identify subclinical acute rejection in kidney transplant recipients, potentially reducing the need for invasive biopsies and allowing for earlier intervention. With Transplant Genomics, we're not just monitoring transplants – we're transforming lives and setting new standards in transplant care.
.png){kind=small}
